These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8206756)

  • 1. A potential vaccine for cocaine abuse prophylaxis?
    Gallacher G
    Immunopharmacology; 1994; 27(1):79-84. PubMed ID: 8206756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hapten optimization for cocaine vaccine with improved cocaine recognition.
    Ramakrishnan M; Kinsey BM; Singh RA; Kosten TR; Orson FM
    Chem Biol Drug Des; 2014 Sep; 84(3):354-63. PubMed ID: 24803171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-cocaine vaccines: antibody protection against relapse.
    Kantak KM
    Expert Opin Pharmacother; 2003 Feb; 4(2):213-8. PubMed ID: 12562311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the effects of hapten stability on cocaine vaccine immunogenicity.
    Cai X; Whitfield T; Moreno AY; Grant Y; Hixon MS; Koob GF; Janda KD
    Mol Pharm; 2013 Nov; 10(11):4176-84. PubMed ID: 23927436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flagellin as carrier and adjuvant in cocaine vaccine development.
    Lockner JW; Eubanks LM; Choi JL; Lively JM; Schlosburg JE; Collins KC; Globisch D; Rosenfeld-Gunn RJ; Wilson IA; Janda KD
    Mol Pharm; 2015 Feb; 12(2):653-62. PubMed ID: 25531528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating cocaine vaccine potency through hapten fluorination.
    Cai X; Tsuchikama K; Janda KD
    J Am Chem Soc; 2013 Feb; 135(8):2971-4. PubMed ID: 23398531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-drug vaccines to treat substance abuse.
    Kinsey BM; Jackson DC; Orson FM
    Immunol Cell Biol; 2009; 87(4):309-14. PubMed ID: 19333250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a therapeutic cocaine vaccine in rodent models.
    Fox BS; Kantak KM; Edwards MA; Black KM; Bollinger BK; Botka AJ; French TL; Thompson TL; Schad VC; Greenstein JL; Gefter ML; Exley MA; Swain PA; Briner TJ
    Nat Med; 1996 Oct; 2(10):1129-32. PubMed ID: 8837612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination.
    Wenthur CJ; Cai X; Ellis BA; Janda KD
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3666-3668. PubMed ID: 28709828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for cocaine abuse.
    Orson FM; Kinsey BM; Singh RA; Wu Y; Kosten TR
    Hum Vaccin; 2009 Apr; 5(4):194-9. PubMed ID: 19276665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cocaine vaccine development.
    Kinsey BM; Kosten TR; Orson FM
    Expert Rev Vaccines; 2010 Sep; 9(9):1109-14. PubMed ID: 20822352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model.
    Kantak KM; Collins SL; Lipman EG; Bond J; Giovanoni K; Fox BS
    Psychopharmacology (Berl); 2000 Feb; 148(3):251-62. PubMed ID: 10755738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human therapeutic cocaine vaccine: safety and immunogenicity.
    Kosten TR; Rosen M; Bond J; Settles M; Roberts JS; Shields J; Jack L; Fox B
    Vaccine; 2002 Jan; 20(7-8):1196-204. PubMed ID: 11803082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potential vaccine for cocaine abuse prophylaxis.
    Bagasra O; Forman LJ; Howeedy A; Whittle P
    Immunopharmacology; 1992; 23(3):173-9. PubMed ID: 1500284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Anti-Cocaine Nanoaccine Successfully Prevents Cocaine-Induced Hyperlocomotion.
    Madge HYR; Alexander S; Azuar A; Zhang J; Koirala P; Burne TH; Toth I; Stephenson RJ
    J Med Chem; 2023 Sep; 66(17):12407-12419. PubMed ID: 37646732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine pharmacotherapy for the treatment of cocaine dependence.
    Martell BA; Mitchell E; Poling J; Gonsai K; Kosten TR
    Biol Psychiatry; 2005 Jul; 58(2):158-64. PubMed ID: 16038686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical issues in using a cocaine vaccine to treat and prevent cocaine abuse and dependence.
    Hall W; Carter L
    J Med Ethics; 2004 Aug; 30(4):337-40. PubMed ID: 15289512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of psychoactive effects of cocaine by active immunization.
    Carrera MR; Ashley JA; Parsons LH; Wirsching P; Koob GF; Janda KD
    Nature; 1995 Dec; 378(6558):727-30. PubMed ID: 7501020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a therapeutic vaccine for the treatment of cocaine addiction.
    Fox BS
    Drug Alcohol Depend; 1997 Dec; 48(3):153-8. PubMed ID: 9449013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current challenges for the creation of effective vaccines against drugs of abuse.
    Moreno AY; Janda KD
    Expert Rev Vaccines; 2011 Dec; 10(12):1637-9. PubMed ID: 22085165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.